INTRODUCTION
Gastric cancer (GC) remains as a chronic disease with a high rate of morbidity and mortality around the world. GC is the fourth most common cancer diagnosed worldwide. [1] In Iran, the overall incidence rate of GC increased from 2.8 in 2000 to 9.1 per 100,000 persons per year in 2005. [2] Although the main cause of GC has been reported to be the infection by Helicobacter pylori, several lifestyle factors including diet has also been indicated to contribute to this cancer. [3] [4] [5] [6] [7] Among dietary factors, Vitamin D status has selected micronutrient intakes and risk of GC. A signifi cant positive association was seen between Vitamin D intake and risk of GC. [11] In the nested case-control study, no signifi cant association was found between serum 25(OH)D concentrations and risk of cardia (relative risk [RR]: 1.11, 95% confi dence interval [CI] : 0.80, 1.55; P = 0.49) or noncardia GC (RR: 1.10, 95% CI: 0.60, 2.01; P = 0.39). [13] Despite these documents, we are aware of no systematic review or meta-analysis of published fi ndings in this regard. Therefore, we performed the present study to systematically review the current evidence on the association between nutritional status of Vitamin D and risk of GC and if possible, to conduct a meta-analysis of published data in this area.
MATERIALS AND METHODS
We performed a systematic review and meta-analysis of studies that examined the association between Vitamin D intake, serum Vitamin D levels, and risk of GC in the adult population.
Literature search strategy
Published evidence in this area was searched through the use of ISI Web of Knowledge, PubMed/Medline, Ovid Database, and Google Scholar for relevant articles. Two authors (SK and PS) independently searched papers published until August 2014 using the following key words: "Vitamin D," "25-OH-D," "25-hyroxy Vitamin D," "1, 25-dihyroxy Vitamin D," "cholecalciferol," "calcidiol," "calcitriol," "hydroxycholecalciferols," "25-hydroxy Vitamin D₃" in combination with "stomach," "gastric," "cancer," "tumor," "tumor," "carcinoma," "adenocarcinoma," or "neoplasm." Finally, the reference lists of included publications were checked to verify the completeness of the literature search. No restriction about the time of publication or language was made.
Inclusion criteria
Duplicate publications were deleted. Each title and abstract was reviewed to clarify whether the article was relevant or not. The full-text was reviewed if the abstract indicated that the article reported the association between Vitamin D intake or serum 25(OH)D levels and risk of GC. English and non-English papers that fulfi lled the following criteria were included in the current study: 1. Case-control or cohort studies or pooling projects, 2. Those that considered Vitamin D intake or serum 25(OH) D concentrations as the exposure variable, 3. Those that regarded GC as the main outcome variable or as one of the outcomes, 4. Those that reported odds ratios (ORs), RRs, rate or risk or hazard ratios as their eff ect size.
Out of 132 retrieved papers in our search, seven articles met the inclusion criteria. The major reasons for exclusion of studies were (a) duplicates and (b) no usable data reported.
Data extraction
Two independent reviewers (SK and PS) extracted the data regarding fi rst author's last name, publication date, sample size, participants' age, gender, methods used for assessing Vitamin D intake or serum 25(OH)D levels, and reported ORs or RRs as well as covariates. Mean, standard deviation, and range of Vitamin D intake or serum 25(OH) D levels was also extracted. In case of having sex-specifi c eff ect sizes reported in the paper, we used these statistics besides the one reported for the whole group, in order to use these eff ect sizes in subgroup analysis and fi nd genderspecifi c association between Vitamin D status and risk of GC. Data extraction was conducted independently by two investigators. Any disagreements were resolved through discussion between the authors.
Statistical methods
The association between Vitamin D intake and serum levels of Vitamin D and GC was separately assessed. Main outcome variables were measures of RRs for the association between Vitamin D intake, serum 25(OH)D levels, and GC. Point estimates of RRs or OR, and 95% CI were estimated for each study. The method of Zhang and Yu was used to correct the tendency of ORs for common events to overestimate the RR. [15] Within-and between-study heterogeneities were assessed using Cochran's Q-statistics, [15] and the heterogeneity test was used to assess the null hypothesis that all studies evaluated the same eff ect. The eff ect of heterogeneity was quantifi ed using I 2 , [16] that provides a measure of the degree of inconsistency between studies and determines whether the percentage total variation across studies is due to heterogeneity rather than chance. I 2 values range between 0% and 100%, and I 2 values of 25%, 50%, and 75% are referred to as low, moderate, and high estimates, respectively. [15] The random eff e cts method [17] was conducted to calculate pooled ORs and 95% CIs, because we found no evidence of heterogeneity. The funnel plot, Begg, and Mazumdar rank correlation test, and Egger's test were employed to assess the publication bias. [18] Although, statistical testing for interaction did not confi rm a signifi cant diff erence between the male and female subgroups, we conducted subgroup analysis to fi nd a gender-specifi c association between Vitamin D status and risk of GC. Sensitivity analysis was conducted to explore the extent to which inferences might depend on a particular study or number of publications. Statistical analyses were conducted using Stata version 11.2 (Stata Corp, College Station, TX, USA). P < 0.05 was considered statistically signifi cant.
to 132 papers; 112 papers were eliminated on examination of abstracts as they were not prospective cohort or case-control studies or did not assess the relationship between Vitamin D and risk of GC. Finally, a er reviewing the titles and abstracts, 20 papers were initially classifi ed as potentially relevant and the full papers retrieved. A er reading full-text of 20 papers, fi nally 7 articles (4 papers for Vitamin D intake and GC and 3 papers for serum Vitamin D concentrations and GC) were included in the meta-analysis. [8] [9] [10] [11] [12] [13] [14] A fl ow diagram that detailed the process is presented in Figure 1 . Although, the reference list of each paper was checked, but we did not identify further relevant studies. No additional articles were identifi ed by searches of other databases.
Summary of studies that assessed Vitamin D intake
The studies included in this systematic review are summarized and alphabetically listed in Table 1 . We found four articles that had reported the association between Vitamin D intake and risk of GC. [10] [11] [12] 14] The publication date for these papers ranged from 1994 [10, 11] to 2008. [12] All these studies were of case-control design. Two studies were conducted in Italy, [11, 12] one in France, [10] and another one in US. [14] One study had reported the association between Vitamin D intake and GC separately for cardia GC and noncardia GC. [14] This study was considered as two separate studies. Others have not clarifi ed if their outcome variable was cardia or noncardia GC. [10] [11] [12] The sample size for all studies combined was 1652 cases (ranging from 92 to 723) and 4067 controls (ranging from 128 to 2024 individuals). All studies had recruited both genders as their subjects. The age range studied in these papers was 19-80 year. Two studies had assessed dietary Vitamin D intake by the use of a diet history questionnaire [10, 11] and two studies had used food frequency questionnaire. [12, 14] One study had reported ORs across tertiles, [10] another one across quintiles [11] and two other studies across quartiles of Vitamin D intake. [12, 14] 
Summary of studies that assessed serum Vitamin D levels
Three articles assessed the association between serum Vitamin D levels and risk of GC. [8] [9] 13] The publication date for these papers ranged between 2006 [9] and 2010. [8] One study was of a nested case-control nature, [13] another one was a prospective cohort study [9] and the other article was a pooling project of eight cohort studies. [8] The follow-up time for the nested case-control study was 5 years [13] and for the cohort study was 14 years. [9] The median follow-up time from blood collection to cancer diagnosis in the pooling project of eight cohort studies was between 1.7 and 11.8 years. [8] In the pooling project paper, no RRs have been given for GC and all estimates had been provided for upper gastrointestinal cancers. The nested case-control and cohort studies had been done in China (n = 1) and US (n = 1), respectively. The pooling project (n = 1) was a collaborative study between Finland, US, China. One study had reported the RRs separately for cardia and noncardia GC, but had not reported the association for these two types of cancer combined. [13] Therefore, this study was also used as two separate studies. For all studies combined, 79,515 subjects had been examined; among them there were 512 individuals with GC and 1065 individuals with upper gastrointestinal cancer were identifi ed. All studies, except the one in men, [9] had enrolled both genders in the study. The age range in these papers was 40-75 years. All studies had considered serum 25(OH)D levels, quantifi ed by ELISA, as the surrogate biomarker of Vitamin D status. The RRs for GC had been presented by quartiles [13] or quintiles. [9] The pooling project had reported RRs for upper gastrointestinal cancers across diff erent levels (<25, 25-<37.5, 37.5-<50, 50-<75, 75-<100 and ≥100 nmol/L) of serum 25(OH)D and had considered serum 25(OH)D level of 50-<75 nmol/L as a reference category. [8] Findings from meta-analysis Vitamin D intake and risk of gastric cancer There were four papers that examined the association between dietary Vitamin D intake and risk of GC; one study that had reported ORs separately for cardia and noncardia GC was included as two separate studies. Therefore, we had fi ve ORs in the meta-analysis on Vitamin D intake and risk of GC. The results of the meta-analysis revealed no signifi cant association between Vitamin D intake and risk of GC. Based on the pooled eff ect size obtained from random eff ects model, the OR (95% CI) for comparison of highest versus lowest intakes of Vitamin D was 1.09 (0.94, 1.25; P = 0.26) [ Figure 2 ]. We found no evidence of between-study heterogeneity (I² = 13.2%, P = 0.33) as well as publication bias using funnel plot (Egger's test P = 0.35).
Serum Vitamin D levels and risk of gastric cancer
We found three papers that assessed the relationship between serum levels of Vitamin D and risk of GC. No significant association was observed between serum Vitamin D levels and risk of GC. The pooled eff ect size, obtained from random eff ects model, for highest versus lowest serum Vitamin D levels was 0.92 (95% CI: 0.74, 1.14; P = 0.42) [ Figure 2 ]. No evidence of heterogeneity was found (I²: 22.5%, P = 0.27); Also funnel plot did not reveal any evidence of publication bias (Egger's test P = 0.69). As some studies had reported a gender-stratifi ed relationship between serum Vitamin D levels and risk of GC, the analyses were performed separately for men and women. Among men, the pooled eff ect size in highest versus lowest category of serum Vitamin D levels was 0.92 (95% CI: 0.71, 1.18, P = 0.49) [ Figure 3 ]. For further assurance of the relationship between serum Vitamin D levels and risk of GC in men, we eliminated one study that investigated the association between serum Vitamin D levels and risk of upper gastrointestinal cancers. Despite removing this study from the analysis, no signifi cant association was observed (Pooled OR: 0.94; 95% CI: 0.66, 1.32; P = 0.70) [ Figure 4 ]. No evidence of heterogeneity was found either for all studies in men (I²: 0%, P = 0.51) or when we removed the one assessed upper GI cancer (I²: 11.3%, P = 0.32). We also failed to fi nd any evidence of publication bias from funnel plot (Egger's test; P = 0.32). We failed to fi nd a signifi cant association between serum levels of Vitamin D and risk of GC in women (Pooled OR: 1.04; 95% CI: 0.74, 1.47; P = 0.80). There was no evidence of heterogeneity and publication bias (I²: 0.0%, P = 0.77; Egger's test P = 0.69, respectively) [ Figure 5 ].
DISCUSSION
In the current meta-analysis, we summarized the results of papers published so far on the association between Vitamin D intake, serum Vitamin D levels, and risk of GC. Overall, no signifi cant association was found between Vitamin D status and risk of GC.
In recent years, numerous studies have reported the associations of circulating 25(OH)D levels with a variety of cancers. Although, inverse associations were rather consistently found for colorectal cancer, [19] fi ndings from studies that assessed the relationship between Vitamin D and breast cancer were more heterogeneous, where strong inverse association has been found in case-control studies, but not in longitudinal studies. [20, 21] No associations have been found for other cancers, such as prostate cancer, [22] but risk increase has been suggested at both the lower and the upper levels of the 25(OH)D distributions. [23] We found a nonsignifi cant positive association between dietary intake of Vitamin D and risk of GC in adult populations. The four papers on Vitamin D intake we included in the current analysis were as follow: (1) A case-control study on nutritional factors and GC among 220 people (92 cases and 128 controls) that was performed in 1994. The sample size of this study was very small in comparison with others. Diet history questionnaire had been used for dietary assessment. The questionnaire was particularly detailed and covered extensively the variety of foods typical of the Mediterranean diet. The authors reached a nonsignifi cant positive relationship between Vitamin D intake and risk of GC (OR: 1.20, 95% CI: 0.60, 2.37; P = 0.61). [10] (2) Another one was a case-control study that investigated the association of selected micronutrient intakes and risk of GC among 723 cases and 2024 controls. The size of this data set allowed suffi cient statistical power to obtain reasonably precise risk estimates for micronutrients. A signifi cant positive association was seen between Vitamin D intake and risk of GC (OR: 1.35, 95% CI: 1.00; 1.83); [11] (3) In an Italian case-control study, the investigators assessed the relationship between dietary intake of selected micronutrients and risk of GC among 230 patients with GC and 547 matched controls. A major strength of this study was the use of a reproducible and valid FFQ for assessing dietary intakes of macro-and micro-nutrients. A nonsignifi cant positive association was found between Vitamin D intake and risk of GC (1.33, 95% CI: 0.80, 2.21; P = 0.67); [12] (4) Another case-control study that was conducted in US assessed the association of nutrient intakes and risk of subtypes of esophageal and GC.
This paper reported the association of Vitamin D intake with risk of gastric cardia-adenocarcinoma and noncardia GC, separately. Totally, 255 patients with gastric cardiaadenocarcinoma, 352 with noncardia GC and 687 controls participated in this study. The strength of this study was considering the use of Vitamin supplements that had not been taken into account in other studies. Again, the authors found no signifi cant association between Vitamin D intake and risk of gastric cardia-adenocarcinoma (OR: 1.05, 95% CI: 0.81, 1.36) or noncardia GC (OR: 0.92, 95% CI: 0.72, 1.16). [14] Taking all studies together, it seems that dietary intake of Vitamin D cannot contribute to the risk of GC; however, the association between high intakes of Vitamin D and risk of GC must be interpreted cautiously. It must be kept in mind that all studies we included in our meta-analysis on Vitamin D intake and risk of GC were of case-control design. A possible limitation inherent in case-control study designs are that cases might have recalled their diet and supplement-taking practices diff erently a er cancer diagnosis. We found no information on H. pylori infection in these studies; while this infection is known as a major determinant of GC. However, case-control studies have limited ability to measure H. pylori because blood samples obtained at stomach cancer diagnosis are of low value.
Our meta-analysis revealed no statistically significant relationship between serum levels of Vitamin D and risk of GC, neither for the whole population nor for gender-stratifi ed analyses. Three studies were included in this meta-analysis: [8, 9, 13] One prospective study that was performed in men, [9] a nested case-control study [13] and a pooling project. [8] In the cohort study, a er following-up the participants for 14 years, 78 GC cases were found. The authors reached a nonstatistically signifi cant but suggestive inverse association between serum 25(OH)D levels and risk of stomach cancer (RR: 0.58, 95% CI: 0.26, 1.33). They found that an increment of 25 nmol/L in 25(OH)D levels was associated with a 43% and 45% reduction in incidence and mortality, respectively, of digestive system cancers. [9] In the nested case-control study, no signifi cant association was found between serum 25(OH)D concentrations and risk of cardia (RR: 1.11, 95% CI: 0.80, 1.55; P = 0.49) or noncardia GC (RR: 1.10, 95% CI: 0.60, 2.01; P = 0.39). [13] One might a ribute the lack of associations between serum Vitamin D levels and risk of GC in the above-mentioned studies to the low incidence of this cancer. However, the same fi ndings were obtained in a pooling project of eight prospective studies from China, Finland, and the United States. [8] The authors of this project failed to fi nd any signifi cant association between 25(OH)D concentrations and risk of upper GI cancers (RR: 0.90, 95% CI: 0.65, 1.24) as well as total GC (RR: 0.77, 95% CI: 0.55, 1.08). The strength of this study was the combination of multiple populations from diverse geographic locations that could provide a wide distribution of exposure variable. Furthermore, using eight cohorts supplied a relatively large sample size. As with all the previous studies, the weakness of this study was also the lack of information on H. pylori status. Taken together, it seems that no signifi cant association exists between low serum Vitamin D status and risk of GC. However, due to limited data in this fi eld, further studies are required to reach a defi nite conclusion.
Several points need to be considered in the interpretation of the current fi ndings. Our systematic review and meta-analysis are the most up-to-date investigation of the worldwide evidence on the association between Vitamin D status and GC. This is the only evidence that included both dietary intake of Vitamin D and serum 25(OH)D levels and assessed their association with GC. Although, methods of assessment of Vitamin D intake were partly diff erent, all studies had used the same method for assessing serum 25(OH)D levels. This might reduce of heterogeneity between studies. Furthermore, given the limited information on both Vitamin D intake and serum Vitamin D levels in relation to GC, additional studies are required.
CONCLUSION
We found no evidence for the significant association between Vitamin D status and risk of GC. However, due to limited data in this fi eld, further studies are required to reach a defi nite conclusion.
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